nach oben

CardioVascular and Interventional Radiology

Erschienen in:

01.04.2014 | Technical Note

Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension

verfasst von: F. Streitparth, B. Gebauer, P. Nickel, P. Reinke, P. Freyhardt, G. Wieners, B. Hamm, R. W. Günther

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

As an alternative to catheter-based radiofrequency (RF) ablation, renal sympathicolysis can also be achieved by image-guided percutaneous injection of ethanol around the renal artery.

Materials and Methods

We report the case of a 50-year-old man with refractory hypertension and end-stage renal failure of unclear etiology who was treated with computed tomography-guided percutaneous periarterial ethanol sympathicolysis.

Results

The procedure was painless. The patient’s BP decreased within 6 days from a baseline value of 172/84 mm Hg (1 week before treatment) to a sustained decreased value of 143/70 mm Hg 1 month after intervention, i.e., a decrease by 29/14 mm Hg. The patient’s hypertension-related headache resolved.

Conclusion

Image-guided periarterial ethanol injection for renal sympathetic denervation in a patient with drug-resistant hypertension is feasible. We provide a detailed description of this new interventional procedure and discuss its potential advantages compared with catheter-based RF ablation.

Wolf-Maier K, Cooper RS, Kramer H et al (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43(1):10–17PubMedCrossRef

Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121(7):e46–e215PubMedCrossRef

Esler M, Jennings G, Korner P et al (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11(1):3–20PubMedCrossRef

Schlaich MP, Lambert E, Kaye DM et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43(2):169–175PubMedCrossRef

Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281PubMedCrossRef

Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903–1909PubMedCrossRef

Investigators SH (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57(5):911–917CrossRef

Esler MD, Krum H, Schlaich M, Schmieder RE, Bohm M, Sobotka PA (2012) Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 126(25):2976–2982PubMedCrossRef

Kandzari DE, Bhatt DL, Sobotka PA et al (2012) Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial. Clin Cardiol 35(9):528–535PubMedCrossRef

10.

Krum H, Sobotka P, Mahfoud F, Bohm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123(2):209–215PubMedCrossRef

11.

Lambert GW, Hering D, Esler MD et al (2012) Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension 60(6):1479–1484PubMedCrossRef

12.

Mahfoud F, Cremers B, Janker J et al (2012) Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60(2):419–424PubMedCrossRef

13.

Ormiston JA, Watson T, van Pelt N et al (2013) First-in-human use of the OneShot renal denervation system from Covidien. EuroIntervention 8(9):1090–1094PubMedCrossRef

14.

Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD (2012) Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr Hypertens Rep 14(3):247–253PubMedCrossRef

15.

Mabin T, Sapoval M, Cabane V, Stemmett J, Iyer M (2012) First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention 8(1):57–61PubMedCrossRef

16.

Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK (2011) Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 100(12):1095–1101PubMedCrossRef

17.

Cook S, Goy JJ, Togni M (2012) Optical coherence tomography findings in renal denervation. Eur Heart J 33(23):2992PubMedCrossRef

18.

Kaltenbach B, Id D, Franke JC et al (2012) Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol 60(25):2694–2695PubMedCrossRef

19.

Vonend O, Antoch G, Rump LC, Blondin D (2012) Secondary rise in blood pressure after renal denervation. Lancet 380(9843):778PubMedCrossRef

20.

Streitparth F, Walter A, Stolzenburg N et al (2013) MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs. Cardiovasc Intervent Radiol 36(3):791–796PubMedCrossRef

21.

Fischell TA, Vega F, Raju N et al (2013) Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model. EuroIntervention 9(1):140–147PubMedCrossRef

22.

Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934PubMedCrossRef

23.

Kocabas H, Salli A, Demir AH, Ozerbil OM (2010) Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study. Eur J Phys Rehabil Med 46(1):5–10PubMed

24.

Moller JE, Helweg-Larsen J, Jacobsen E (1969) Histopathological lesions in the sciatic nerve of the rat following perineural application of phenol and alcohol solutions. Dan Med Bull 16(4):116–119PubMed

25.

Wilkes D, Ganceres N, Doulatram G, Solanki D (2009) Alcohol neurolysis of the sciatic and femoral nerves to improve pressure ulcer healing. Pain Pract 9(2):145–149PubMedCrossRef

26.

Atherton DS, Deep NL, Mendelsohn FO (2012) Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25(5):628–633PubMedCrossRef

27.

Stefanadis C, Toutouzas K, Synetos A et al (2013) Chemical denervation of the renal artery by vincristine in swine. A new catheter based technique. Int J Cardiol 167(2):421–425PubMedCrossRef

28.

Esler M, Schlaich M, Sobotka P et al (2009) Catheter-based renal denervation reduces total body and renal noradrenaline spillover and blood pressure in resistant hypertension. J Hypertens 27(Suppl 4):s167

Titel: Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension
verfasst von: F. Streitparth
B. Gebauer
P. Nickel
P. Reinke
P. Freyhardt
G. Wieners
B. Hamm
R. W. Günther
Publikationsdatum: 01.04.2014
Verlag: Springer US
Erschienen in: CardioVascular and Interventional Radiology / Ausgabe 2/2014
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-014-0850-0

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension

Abstract

Purpose

Materials and Methods

Results

Conclusion

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie

Springer Medizin

Abstract

Purpose

Materials and Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Massive Subcutaneous and Mediastinal Emphysema with Little Pneumothorax Treated by Surgery after Pulmonary Radiofrequency Ablation

Radiofrequency Ablation is a Valuable Therapeutic Option in the Treatment of Liver Metastases From Gastrointestinal Stromal Tumors

Transrenal Ureteral Occlusion Using the Amplatzer Vascular Plug II: A New Interventional Treatment Option for Lower Urinary Tract Fistulas

Ultrasound-Guided Transhepatic Radiofrequency Ablation of Renal Tumors: A Safe and Effective Approach

Anatomic Risk Factors for Type-2 Endoleak Following EVAR: A Retrospective Review of Preoperative CT Angiography in 326 patients

A Case of Pulmonary Aspergilloma Treated with Radiofrequency Ablation

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie